Now showing items 1-1 of 1
-
RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model Ignatoski, Kathleen M. Woods; Escara-Wilke, June; Dai, Jinlu; Lui, A.; Dougall, William C.; Daignault, Stephanie D.; Yao, Zhi; Zhang, J.; Day, Mark L.; Sargent, E. E.; Keller, Evan T. (Wiley Subscription Services, Inc., A Wiley Company, 2008-06-01)